Procedural Advantages of a Novel Drug-Eluting Coronary Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 814 participants.

Also called NCT02881216

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 814 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02881216
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02881216. Non-randomized; no masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Procedural Advantages of a Novel Drug-Eluting Coronary Stent
Intervention (Device)
Synergy Stent
Intervention (Device)
Currently common drug-eluting stent (DES)
Lead sponsor
University Hospital Heidelberg (class: other)

Record details

Record id
cardio:ct-nct02881216
Content hash
083c66228c45dd0b331253a89f71874db88ed55c1b5772ad0ec6f97e806b13bc